Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease

References

• Weatherall, D. (1999). Disorders of the synthesis or function of haemoglobin. In: Oxford Textbook of Medicine, Edited by Weatherall, D., Ledingham, J. and Warrell, D., Oxford University Press.
   Google Scholar
• Stamatoyannopoulos, G. and Nienhuis, A. (1994). Hemoglobin Switching. In: The Molecular Basis of Blood Diseases, Edited by Stamatoyannopoulos, G., Neinhuis, A., Majerus, P., and Varmus, H., 107–155. W. B. Saunders Co.
   Google Scholar
• Eaton, J. (1994). Malaria and the sickle cell gene. In: Sickle Cell Disease Basic Principles and Clinical Practice, Edited by Embury, S., Hebbel, R., Mohandas, N. and Steinberg, M., 13–18. Raven Press.
   Google Scholar
• Weatherall, D. (1994). The thalassemias. In: The Molecular Basis of Blood Diseases., Edited by Stamatoyannopoulos, G., Nienhuis, A., Majerus, P. and Varmus, H., 157–206. W. B. Saunders Co.
   Google Scholar
• Noguchi, C., Rodgers, G. and Schecter, A. (1989). Intracellular polymerization; disease severity and therapeutic predictions. Ann. NY Acad. Sci., 565, 75–82.
   PubMed Web of Science ®Google Scholar
• Perrine, R., Brown, M., Clegg, J., Weatherall, D. and May, A. (1972). Benign sickle-cell anaemia. Lancet, 2, 1163–1167.
   PubMed Web of Science ®Google Scholar
• Weatherall, D., Clegg, J. and Wood, W. (1976). A model for the persistence or reactivation of fetal haemoglobin production. Lancet, 25, 660–663.
   Google Scholar
• Wood, W., Weatherall, D. and Clegg, J. (1976). Interaction of heterocellular hereditary persistence of foetal haemoglobin with beta thalassaemia and sickle cell anaemia. Nature, 18, 247–249.
   Google Scholar
• Olivieri, N. (1996). Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin. Hematol., 33, 24–42.
   PubMed Web of Science ®Google Scholar
• Bunn, H. (1999). Induction of fetal hemoglobin in sickle cell disease. Blood, 15, 1787–1789.
   Google Scholar
• Walters, M., Patience, M., Leisenring, W., Eckman, J., Scott, J., Mentzer, W., Davies, S., Ohene-Frempong, K., Bemaudin, F., Matthews, D., Storb, R. and Sullivan, K. (1996). Bone marrow transplantation for sickle cell disease. N. Engl. J. Med., 8, 369–376.
   Google Scholar
• Platt, O. and Guinan, E. (1996). Bone marrow transplantation in sickle cell anemia—the dilemma of choice. N. Engl. J. Med., 8, 426–428.
   Google Scholar
• Lawn, R., Fitsch, E., Parker, R., Blake, G. and Maniatis, T. (1978). The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA. Cell, 15, 1157–1174.
   PubMed Web of Science ®Google Scholar
• Smithies, O., Blechl, A., Denniston-Thompson, K., Newel, N., Richards, J., Slightom, J., Tucker, P. and Blattner, F. (1978). Cloning human fetal gamma globin and mouse alpha-type globin DNA: characterization and partial sequencing. Science, 202, 1284–1289.
   PubMed Web of Science ®Google Scholar
• Proudfoot, N. and Baralle, F. (1979). Molecular cloning of human epsilon-globin gene. Proc. Natl. Acad. Sci., 76, 5435–5439.
   PubMed Web of Science ®Google Scholar
• Office of Recombinant DNA Activities (ORDA); Update 2/10/99. ORDA Website. http://www.nih.gov/od/orda/index.html
   Google Scholar
• Wiley Gene Medicine Website Database; Update 3/1/99. http://www.wiley.co.uk/wileychi/genmed/clinical/index.html#copy
   Google Scholar
• Anderson, W. F. (1998). Human gene therapy. Nature, 392 (Suppl), 25–30.
   PubMedGoogle Scholar
• Smith, A. E. (1995). Viral vectors in gene therapy. Annu. Rev. Microbiol., 49, 807–838.
   PubMed Web of Science ®Google Scholar
• Orlic, D., Girard, L. J., Jordan, C. T., Anderson, S. M., Cline, A. P. and Bodine, D. M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci., 93, 11097–102.
   PubMed Web of Science ®Google Scholar
• Kohn, D., Weinberg, K., Nolta, J., Heiss, L., Lenarsky, C., Crooks, G., Hanley, M., Annett, G., Brooks, J. and el-Khoureiy, A. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med., 1, 1017–1023.
   PubMed Web of Science ®Google Scholar
• Dunbar, C., Cottler-Fox, M., O'Shaughnessy, J., Doren, S., Carter, C., Berenson, R., Brown, S., Moen, R., Greenblatt, J. and Stewart, F. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood, 85, 3048–3057.
   PubMed Web of Science ®Google Scholar
• Orlic, D., Girard, L. J., Anderson, S. M., Pyle, L. C., Yoder, M. C., Broxmeyer, H. E. and Bodine, D. M. (1998). Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors. Blood, 91, 3247–54.
   PubMed Web of Science ®Google Scholar
• Bodine, D. M., Crosier, P. S. and Clark, S. C. (1991). Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. Blood, 78, 914–20.
   PubMed Web of Science ®Google Scholar
• Bodine, D. M., McDonagh, K. T., Seidel, N. E. and Nienhuis, A. W. (1991). Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp. Hematol., 19, 206–12.
   PubMed Web of Science ®Google Scholar
• Burns, J. C., Friedmann, T., Driever, W., Burrascano, M. and Yee, J. K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci., 90, 8033–8037.
   PubMed Web of Science ®Google Scholar
• Uchida, N., Sutton, R., Friera, A., He, D., Reitsma, M., Chang, W., Veres, G., Scollay, R. and Weissman, I. (1998). HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci., 95, 11939–11944.
   PubMed Web of Science ®Google Scholar
• Jane, S. M., Ney, P. A., Vanin, E. F., Gumucio, D. L. and Nienhuis, A. W. (1992). Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5′ HS2 enhancer when in competition with the beta-promoter. EMBO J., 11, 2961–9.
   PubMed Web of Science ®Google Scholar
• Jane, S., Amrolia, P. and Cunningham, J. (1995). Developmental regulation of the human beta-globin cluster. Aust. NZ J. Med., 25, 865–869.
   PubMedGoogle Scholar
• Orkin, S. H. and Motulsky, A. G. (1995). Report and recommendations of the panel to assess the NIH investment in research on gene therapy. Office of Recombinant DNA activites, NIH.
   Google Scholar
• Wolffe, A. (1995). Chromatin: Structure and Function. Academic Press.
   Google Scholar
• Felsenfeld, G. (1992). Chromatin as an essential part of the transcriptional mechanism. Nature, 355, 219–24.
   PubMed Web of Science ®Google Scholar
• Rivella, S. and Sadelain, M. (1998). Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Sem. Hematol, 35, 112–25.
   PubMed Web of Science ®Google Scholar
• Ng, H. and Bird, A. (1999). DNA methylation and chromatin modification. Curr. Opin. Genet. Dev., 9, 158–163.
   PubMed Web of Science ®Google Scholar
• Hoeben, R. C., Migchielsen, A. A. J., Jagt, R. C. M. v. d., Ormondt, H. v. and Eb, A. J. v. D. (1991). Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol., 65, 904–912.
   PubMed Web of Science ®Google Scholar
• Palmer, T. D., Rosman, G. J., Osborne, W. R. A. and Miller, A. D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci., 88, 1330–1334.
   PubMed Web of Science ®Google Scholar
• St. Louis, D. and Verma, I. (1988). An alternative approach to somatic cell gene therapy. Proc. Natl. Acad. Sci., 85, 3150–3154.
   PubMed Web of Science ®Google Scholar
• Chada, K., Magram, J., Raphael, K., Radice, G., Lacy, E. and Costani, F. (1985). Specific expression of a foreign beta-globin in erythroid cells of transgenic mice. Nature, 314, 377–380.
   PubMed Web of Science ®Google Scholar
• Antoniou, M., deBoer, E., Habets, G. and Grosveld, F. (1988). The human, β-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers. EMBO J., 7, 377–384.
   PubMed Web of Science ®Google Scholar
• Tuan, D., Solomon, W., Li, Q. and London, I. (1985). The beta-like-globin gene domain in human erythroid cells. Proc. Natl. Acad. Sci., 82, 6384–6388.
   PubMed Web of Science ®Google Scholar
• Grosveld, F., Blom van Assendelft, G., Greaves, D. and Kollias, G. (1987). Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell, 51, 975–985.
   PubMed Web of Science ®Google Scholar
• Curtin, P., Liu, D., Liu, W., Chang, J. and Kan, Y. (1989). Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc. Natl. Acad. Sci., 86, 7082–7086.
   PubMed Web of Science ®Google Scholar
• Collis, P., Antoniou, M. and Grosveld, F. (1990). Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J., 9, 233–240.
   PubMed Web of Science ®Google Scholar
• Caterina, J. J., Ryan, T. M., Pawlik, K. M., Palmiter, R. D., Brinster, R. L., Behringer, R. R. and Townes, T. M. (1991). Human beta-globin locus control region: analysis of the 5′ DNase I hypersensitive site HS 2 in transgenic mice. Proc. Natl. Acad. Sci., 88, 1626–30.
   PubMed Web of Science ®Google Scholar
• Caterina, J. J., Ciavatta, D. J., Donze, D., Behringer, R. R. and Townes, T. M. (1994). Multiple elements in human beta-globin locus control region 5′ HS 2 are involved in enhancer activity and position-independent, transgene expression. Nucleic Acids Res., 22, 1006–11.
   PubMed Web of Science ®Google Scholar
• Liu, D., Chang, J. C., Moi, P., Liu, W., Kan, Y. W. and Curtin, P. T. (1992). Dissection of the enhancer activity of beta-globin 5′ DNase I-hypersensitive site 2 in transgenic mice. Proc. Natl. Acad. Sci., 89, 3899–903.
   PubMed Web of Science ®Google Scholar
• Lowrey, C. H., Bodine, D. M. and Nienhuis, A. W. (1992). Mechanism of DNase I hypersensitive site formation within the human globin locus control region. Proc. Natl. Acad. Sci., 89, 1143–7.
   PubMed Web of Science ®Google Scholar
• Philipsen, S., Talbot, D., Frase, P. and Grosveld, F. (1990). The beta-globin dominant control region: hypersensitive site 2. EMBO J., 9, 2159–2167.
   PubMed Web of Science ®Google Scholar
• Philipsen, S., Pruzina, S. and Grosveld, F. (1993). The minimal requirements for activity in transgenic mice of hypersensitive site 3 of the beta globin locus control region. EMBO J., 12, 1077–85.
   PubMed Web of Science ®Google Scholar
• Pruzina, S., Hanscombe, O., Whyatt, D., Grosveld, F. and Philipsen, S. (1991). Hypersensitive site 4 of the human beta globin locus control region. Nucleic Acids Res., 19, 1413–9.
   PubMed Web of Science ®Google Scholar
• Talbot, D., Collis, P., Antoniou, M., Vidal, M., Grosveld, F. and Greaves, D. (1989). A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature, 338, 352–355.
   PubMed Web of Science ®Google Scholar
• Talbot, D., Philipsen, S., Fraser, P. and Grosveld, F. (1990). Detailed analysis of the site 3 region of the human beta-globin dominant control region. EMBO J., 9, 2169–2178.
   PubMed Web of Science ®Google Scholar
• Orkin, S. H. (1995). Regulation of globin gene expression in erythroid cells. Eur. J. Biochem., 231, 271–81.
   PubMedGoogle Scholar
• Pomerantz, O., Goodwin, A. J., Joyce, T. and Lowrey, C. H. (1998). Conserved elements containing NF-E2 and tandem GATA binding sites are required for erythroid-specific chromatin structure reorganization within the human beta-globin locus control region. Nucleic Acids Res., 26, 5684–91.
   PubMed Web of Science ®Google Scholar
• Stamatoyannopoulos, J. A., Goodwin, A., Joyce, T. and Lowrey, C. H. (1995). NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region. EMBO J., 14, 106–16.
   PubMed Web of Science ®Google Scholar
• Fraser, P., Hurst, J., Collis, P. and Grosveld, F. (1990). DNaseI hypersensitive sites 1, 2 and 3 of the human beta-globin dominant control region direct position-independent expression. Nucleic Acids Res., 18, 3503–3508.
   PubMed Web of Science ®Google Scholar
• Forrester, W. C., Novak, U., Gelinas, R. and Groudine, M. (1989). Molecular analysis of the human β-globin locus activation region. Proc. Natl. Acad. Sci., 86, 5439–5443.
   PubMed Web of Science ®Google Scholar
• Ellis, J., Tan-Un, K. C., Harper, A., Michalovich, D., Yannoutsos, N., Philipsen, S. and Grosveld, F. (1996). A dominant chromatin-opening activity in 5′ hyper-sensitive site 3 of the human beta-globin locus control region. EMBO J., 15, 562–8.
   PubMed Web of Science ®Google Scholar
• Tuan, D., Solomon, W., Cavallesco, R., Huang, G. and London, I. (1989). Characterization of a human globin enhancer element. Prog. Clin. Biol. Res., 316A, 63–72.
   PubMedGoogle Scholar
• Chang, J. C., Liu, D. and Kan, Y. W. (1992). A 36-base-pair core sequence of locus control region enhances retrovirally transferred human beta-globin gene expression. Proc. Natl. Acad. Sci., 89, 3107–10.
   PubMed Web of Science ®Google Scholar
• Ney, P., Sorrentino, B., McDonagh, K. and Nienhuis, A. (1990). Tandem AP-l-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev., 4, 993–1006.
   PubMed Web of Science ®Google Scholar
• Pasceri, P., Pannell, D., Wu, X. and Ellis, J. (1998). 5′ HS1 and the distal beta-globin promoter functionally interact in single copy beta-globin transgenic mice. Ann. NY Acad. Sci., 850, 377–81.
   PubMed Web of Science ®Google Scholar
• Li, Q. and Stamatoyannopoulos, G. (1994). Hypersensitive site 5 of the human beta locus control region functions as a chromatin insulator. Blood, 84, 1399–401.
   PubMed Web of Science ®Google Scholar
• Grosveld, F., Antoniou, M., Berry, M., de Boer, E., Dillon, N., Ellis, J., Fraser, P., Hurst, J., Imam, A., Meijer, D. et al. (1993). Regulation of human globin gene switching. Cold Spring Harb. Symp. Quant, Biol., 58, 7–13.
   PubMedGoogle Scholar
• Hunter, E. (1997). Viral entry and receptors. In: Retroviruses, Edited by Coffin, J. M., Hughes, S. H. and Varmus, H. E., 71–121, Cold Spring Harbor Laboratory Press.
   Google Scholar
• Brown, P. O (1997). Integration. In: Retroviruses, Edited by Coffin, J. M, Hughes, S. H and Varmus, H. E, 161–205, Cold Spring Harbor Laboratory Press.
   Google Scholar
• Miller, A. D. (1997). Development and application of retroviral vectors. In: Retroviruses, Edited by Coffin, J.M, Hughes, S. H and Varmus, H. E, 437–473, Cold Spring Harbor Laboratory Press.
   Google Scholar
• Wivel, N. A. and Wilson, J. M. (1998). Methods of gene delivery. Hematol. Oncol. Clin. North Am., 12, 483–501.
   PubMed Web of Science ®Google Scholar
• Walsh, C. E., Liu, J. M., Xiao, X., Young, N. S., Nienhuis, A. W. and Samulski, R. J. (1992). Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci., 89, 7257–61.
   PubMed Web of Science ®Google Scholar
• Hargrove, P. W., Vanin, E. F., Kurtzman, G. J. and Nienhuis, A. W. (1997). High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3′ gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood, 89, 21–775.
   Web of Science ®Google Scholar
• Bertran, J., Yang, Y., Hargrove, P., Vanin, E. F. and Nienhuis, A. W. (1998). Targeted integration of a recombinant globin gene adeno-associated viral vector into human chromosome 19. Ann. NY Acad. Sci. 850, 163–77.
   PubMed Web of Science ®Google Scholar
• Kafri, T., Van Praag, H., Ouvang, L., Gage, F. H. and Verma, I. M. (1999). A packaging cell line for lentivirus vectors. J. Virol., 73, 576–584.
   PubMed Web of Science ®Google Scholar
• Cone, R., Weber-Benarous, A., Baorto, D. and Mulligan, R. (1987). Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol. Cell. Biol., 7, 887–897.
   PubMed Web of Science ®Google Scholar
• Lerner, N., Brigham, S., Goff, S. and Bank, A. (1987). Human beta-globin gene expression after gene transfer using retroviral vectors. DNA, 6, 573–582.
   PubMedGoogle Scholar
• Karlsson, S., Papayannopoulou, T., Schweiger, S., Stamatoyannopoulos, G. and Nienhuis, A. (1987). Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc. Natl. Acad. Sci., 84, 2411–2415.
   PubMed Web of Science ®Google Scholar
• Dzerizak, E., Papayannopoulou, T. and Mulligan, R. (1988). Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature, 331, 35–41.
   PubMed Web of Science ®Google Scholar
• Karlsson, S., Bodine, D., Perry, L., Papayannopoulou, T. and Nienhuis, A. (1988). Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic stem cells. Proc. Natl. Acad. Sci., 85, 6062–6066.
   PubMed Web of Science ®Google Scholar
• Bender, M., Miller, A. and Gelinas, R. (1988). Expression of the human beta-globin gene after retroviral transfer into murine ervthroleukemia cells and human BFU-E cells. Mol. Cell. Biol., 8, 1725–1735.
   PubMed Web of Science ®Google Scholar
• Miller, A., Bender, M., Harris, E., Kaleko, M. and Gelinas, R. (1988). Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J. Virol., 62, 4337–4345.
   PubMed Web of Science ®Google Scholar
• Sadelain, M., Wang, C. H., Antoniou, M., Grosveld, F. and Mulligan, R. C. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl. Acad. Sci. 92, 6728–32.
   PubMed Web of Science ®Google Scholar
• Leboulch, P., Huang, G. M., Humphries, R. K., Oh, Y. H., Eaves, C.J., Tuan, D. Y. and London, I. M. (1994). Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J., 13, 3065–76.
   PubMed Web of Science ®Google Scholar
• Shimotohno, K. and Temin, H. M. (1982). Loss of intervening sequences in genomic mouse α-globin DNA inserted in an infectious retroviral vector. Nature, 299, 265–268.
   PubMed Web of Science ®Google Scholar
• Bender, M., Gelinas, R. and Miller, A. (1989). A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells. Mol. Cell. Biol., 9, 1426–1434.
   PubMed Web of Science ®Google Scholar
• Behringer, R., Hammer, R., Brinster, R., Palmiter, R. and Townes, T. (1987). Two 3′ sequences direct erythroid-specific expression of human beta-globin genes in transgenic mice. Proc. Natl. Acad. Sci., 84, 7056–7060.
   PubMed Web of Science ®Google Scholar
• Kollias, G., Hurst, J., de Boer, E. and Grosveld, F. (1987). The human beta-globin gene contains a downstream developmental specific enhancer. Nucleic Acids Res., 15, 5379–5747.
   Web of Science ®Google Scholar
• Trudell, M. and Costantini, F. (1987). A 3′ enhancer contributes to the stage-specific expression of the human beta-globin gene. Genes Dev., 1, 954–961.
   PubMed Web of Science ®Google Scholar
• Novak, U., Harris, E., Forrester, W., Groudine, M. and Gelinas, R. (1990). High level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. Proc. Natl. Acad. Sci., 87, 3386–3390.
   PubMed Web of Science ®Google Scholar
• Ryan, T., Behringer, R., Martin, N., Townes, T., Palmiter, R. and Brinster, R. (1989). A single ervthroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice. Genes Dev., 3, 314–323.
   PubMed Web of Science ®Google Scholar
• Gelinas, R., Frazier, A. and Harris, E. (1992). A normal level of beta-globin expression in erythroid cells after retroviral transfer. Bone Marrow Transplant., 9 (suppl. 1), 154–157.
   PubMedGoogle Scholar
• Plavec, I., Papayannopoulou, T., Maury, C. and Meyer, F. (1993). A human beta-globin gene fused to the human beta-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. Blood, 81, 1384–92.
   PubMed Web of Science ®Google Scholar
• Raftopoulos, H., Ward, M., Leboulch, P. and Bank, A. (1997). Long-term transfer and expression of the human beta-globin gene in a mouse transplant model. Blood, 90, 3414–22.
   PubMed Web of Science ®Google Scholar
• Raftopoulos, H., Ward, M. and Bank, A. (1998). High-level transfer and long-term expression of the human beta-globin gene in a mouse transplant model. Ann. NY Acad. Sci., 850, 178–90.
   PubMed Web of Science ®Google Scholar
• Karpen, G. (1994). Position-effect variegation and the new biology of heterochromatin. Curr. Opin. Gen. Dev., 4, 281–291.
   PubMed Web of Science ®Google Scholar
• Martin, D. and Whitelaw, E. (1996). The vagaries of variegating transgenes. Bioessays, 18, 919–923.
   PubMedGoogle Scholar
• Challita, P. M. and Kohn, D. B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci., 91, 2567–71.
   PubMed Web of Science ®Google Scholar
• Challita, P. M., Skelton, D., el-Khoueiry, A., Yu, X.J., Weinberg, K. and Kohn, D. B. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol., 69, 748–55.
   PubMed Web of Science ®Google Scholar
• Petersen, R., Kempler, G. and Barklis, E. (1991). A stem cell-specific silencer in the primerbinding site of a retrovirus. Mol. Cell. Biol., 11, 1214–1221.
   PubMed Web of Science ®Google Scholar
• Jahner, D. and Jaenisch. (1985). Retrovirus-induced de novo methylation of flanking host sequences correlates with gene activity. Nature, 315, 594–597.
   PubMed Web of Science ®Google Scholar
• Wang, L., Robbins, P. B., Carbonaro, D. A. and Kohn, D. B. (1998). Highresolution analysis of cytosine methylation in the 5 long terminal repeat of retroviral vectors. Hum. Gene Ther., 9, 2321–30.
   PubMed Web of Science ®Google Scholar
• Chen, W. Y., Bailey, E. C., McCune, S. L., Dong, J. Y. and Townes, T. M. (1997). Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci., 94, 5798–803.
   PubMed Web of Science ®Google Scholar
• Grez, M., Akgun, E., Hilberg, F. and Ostertag, W. (1990). Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci., 87, 9202–9206.
   PubMed Web of Science ®Google Scholar
• Robbins, P. B., Skelton, D. C., Yu, X. J., Halene, S., Leonard, E. H. and Kohn, D. B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci., 95, 10182–7.
   PubMed Web of Science ®Google Scholar
• Nolta, J., Dao, M., Wells, S., Smogorzewska, E. and Kohn, D. (1996). Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci., 93, 2414–2419.
   PubMed Web of Science ®Google Scholar
• Cheng, L., Du, C., Lavau, C., Chen, S., Tong, J., Chen, B. P., Scollay, R., Hawley, R. G. and Hill, B. (1998). Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood, 92, 83–92.
   PubMed Web of Science ®Google Scholar
• Kioussis, D., Vanin, E., deLange, T., Flavell, R. and Grosveld, F. (1983). Betaglobin gene inactivation by DNA translocation in γβ-thalassemia. Nature, 306, 662–666.
   PubMed Web of Science ®Google Scholar
• Driscoll, M., Dobkin, C. and Alter, B. (1989). γδβ thalassemia due to a de novo mutation deleting the 5′ β-globin gene activation region hypersensitive sites. Proc. Natl. Acad. Sci., 86, 7470–7474.
   PubMed Web of Science ®Google Scholar
• Curtin, P., Piratsu, M., Kan, Y., Gobert-Jones, J., Stephens, S. and Lehmann, H. (1985). A distant gene deletion affects β-globin in an atypical γδβ thalassemia. J. Clin. Invest., 76, 1554–1558.
   PubMed Web of Science ®Google Scholar
• Forrester, W. C., Epner, E., Driscoll, M. C., Enver, T., Brice, M., Papayannopoulou, T. and Groudine, M. (1990). A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev., 4, 1637–1649.
   PubMed Web of Science ®Google Scholar
• Ellis, J., Pasceri, P., Tan-Un, K. C., Wu, X., Harper, A., Fraser, P. and Grosveld, F. (1997). Evaluation of beta-globin gene therapy constructs in single copy transgenic mice. Nucleic Acids Res., 25, 1296–302.
   PubMed Web of Science ®Google Scholar
• Ellis, J., Osborne, C., Pannell, D., Rubin, J., Pasceri, P., Karaiskakis, A., Sukonnik, T., Wu, T. and Lipshitz, H. (1998). Breaking the code of silence (abstract). Blood Cells Mol. Dis., 24, 471.
   Google Scholar
• Pawlik, K. M. and Townes, T. M. (1995). Autonomous, erythroid-specific DNase I hypersensitive site formed by human beta-globin locus control region (LCR) 5′ HS 2 in transgenic mice. Dev. Biol, 169, 728–32.
   PubMed Web of Science ®Google Scholar
• Fraser, P., Pruzina, S., Antoniou, M. and Grosveld, F. (1993). Each hypersensitive site of the human beta-globin locus control region confers a different developmental pattern of expression on the globin genes. Genes Dev., 7, 106–13.
   PubMed Web of Science ®Google Scholar
• Armstrong, J, and Emerson, B. (1996). NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro. Mol. Cell. Biol., 16, 5634–5644.
   PubMed Web of Science ®Google Scholar
• Gong, Q., McDowell, J. and Dean, A. (1996). Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5′ hypersensitive site 2 of the beta-globin locus control region. Mol. Cell. Biol., 16, 6055–6064.
   PubMed Web of Science ®Google Scholar
• Boyes, J., Omichinski, J., Clark, D., Pikaart, M. and Felsenfeld, G. (1998). Perturbation of nucleosome structure by the erythroid transcription factor GATA-1. J. Mol. Biol., 279, 529–544.
   PubMed Web of Science ®Google Scholar
• Iler, N., Goodwin, A., McInerney, J., Nemeth, M., Pomerantz, O., Layon, M. and Lowrey, C. (1999). Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing. Blood Cells Mol. Dis., 25, 47–60.
   PubMed Web of Science ®Google Scholar
• Hebbes, T. R., Clayton, A. L., Thorne, A. W. and Crane-Robinson, C. (1994). Core histone hyperacetylation comaps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J., 13, 1823–1830.
   PubMed Web of Science ®Google Scholar
• Reitman, M., Lee, E., Westphal, H. and Felsenfeld, G. (1990). Site-independent expression of the chicken beta A-globin gene in transgenic mice. Nature, 348, 749–752.
   PubMed Web of Science ®Google Scholar
• Chung, J. H., Whiteley, M. and Felsenfeld, G. (1993). A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell, 74, 505–14.
   PubMed Web of Science ®Google Scholar
• Chung, J. H., Bell, A. C. and Felsenfeld, G. (1997). Characterization of the chicken beta-globin insulator. Proc. Natl. Acad. Sci., 94, 575–80.
   PubMed Web of Science ®Google Scholar
• Pikaart, M. J., Recillas-Targa, F. and Felsenfeld, G. (1998). Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev., 12, 2852–62.
   PubMed Web of Science ®Google Scholar
• Walters, M., Fiering, S., Bouhassira, E., Scalzo, D., Goeke, S., Magis, W., Garrick, D., Whitelaw, E. and Martin, D. (1999). The chicken beta-globin 5′ HS4 boundary element blocks enhancer-meditated suppression of silencing. Mol. Cell. Biol., 19, 3714–3726.
   PubMed Web of Science ®Google Scholar
• Rivella, S., Callegari, J., May, C. and Sadelain, M. (1998). The insulator element cHS4 increases expression and prevents promotor methylation of integrated retroviral vectors (abstract). Blood Cells Mol. Dis., 24, 483.
   Google Scholar
• Emery, D., Knibbe, M., Felsenfeld, G., Bell, A. and Stamatoyannopoulos, G. (1998). Investigation of genetic insulators in retrovirus vectors. Blood Cells Mol. Dis., 24, 494–495.
   Google Scholar
• Jarman, A. P. and Higgs, D. R. (1989). Sites of attachment to the nuclear scaffold in the human alpha and beta globin gene complexes. Prog. Clin. Biol. Res., 316B, 33–45.
   PubMedGoogle Scholar
• Berezney, R. and Coffey, D. (1974). Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun., 60, 1410–1417.
   PubMed Web of Science ®Google Scholar
• Benyajati, C. and Worcel, A. (1976). Isolation, characterization and structure of the folded interphase genome of Drosophila melanogaster. Cell, 9, 393–407.
   PubMed Web of Science ®Google Scholar
• Cook, P. and Brazell, I. (1975). Supercoils in human DNA. J. Cell Sci. 19, 261–279.
   PubMed Web of Science ®Google Scholar
• Laemmli, U., Kas, E., Poljak, L. and Adachi, Y. (1992). Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev., 2, 275–285.
   PubMedGoogle Scholar
• Guyre, C., Goodwin, A., Stamatoyannopoulos, G. and Lowrey, C. (1995). Long range chromatin structure of the human β-globin gene locus (abstract). Blood, 86, 6a.
   Web of Science ®Google Scholar
• Yu, J., Bock, J., Slighton, J. and Villeponteau, B. (1994). A 5′ beta-globin matrix attachment region and the polyoma enhancer together confer position-independent transcription. Gene, 139, 139–145.
   PubMed Web of Science ®Google Scholar
• Jackson, J., Petrykowska, H., Philipsen, S., Miller, W. and Hardisson, R. (1996). Role of DNA sequences outside the cores of DNase hypersensitive sites in functions of the beta-globin locus control region. J. Biol. Chem., 271, 11871–11878.
   PubMed Web of Science ®Google Scholar
• Zafarana, G., Raguz, S., Pruzina, S., Grosveld, F. and Meijer, D. (1995). The regulation of human beta-globin gene expression: the analysis of hypersensitive site 5 (HS5) in the LCR. In: Molecular Biology of Hemoglobin Switching, Edited by Stamatoyannopoulos, G., 39–44, Intercept.
   Google Scholar
• Kellum, R. and Schedl, P. (1992). A group of scs elements function as domain boundaries in an enhancerblocking assay. Mol. Cell. Biol., 12, 2424–2431.
   PubMed Web of Science ®Google Scholar
• Cunningham, J. M., Purucker, M. E., Jane, S. M., Safer, B., Vanin, E. F., Ney, P. A., Lowrey, C. H. and Nienhuis, A. W. (1994). The regulatory element 3′ to the A gamma globin gene binds to the nuclear matrix and interacts with special A-T-rich binding protein 1 (SATB1), an SAR/MAR-associating region DNA binding protein. Blood, 84, 1298–308.
   PubMed Web of Science ®Google Scholar
• Bodine, D. M. and Ley, T. J. (1987). An enhancer element lies 3′ to the human A gamma globin gene. EMBO J., 6, 2997–3004.
   PubMed Web of Science ®Google Scholar
• Li, Q. and Stamatoyannopoulos, J. A. (1994). Position independence and proper developmental control of gamma-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol. Cell. Biol., 14, 6087–96.
   PubMed Web of Science ®Google Scholar
• Stamatoyannopoulos, J. A., Clegg, C. H. and Li, Q. (1997). Sheltering of gamma globin expression from position effects requires both an upstream locus control region and a regulatory element 3′ to the A gamma-globin gene. Mol. Cell. Biol., 17, 240–7.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Tanimoto, K., Bungert, J. and Engel, J. D. (1998). The A gamma-globin 3′ element provides no unique function(s) for human beta-globin locus gene regulation. Proc. Natl. Acad. Sci., 95, 9944–9.
   PubMed Web of Science ®Google Scholar
• Langdon, S. and Kaufman, R. (1998). Gamma-globin gene promoter elements required for interaction with globin enhancers. Blood, 91, 309–318.
   PubMed Web of Science ®Google Scholar
• Jarman, A. P., Wood, W. G., Sharpe, J. A., Gourdon, G., Ayyub, H. and Higgs, D. R. (1991). Characterization of the major regulatory element upstream of the human alpha globin gene cluster. Mol. Cell. Biol., 11, 4679–89.
   PubMed Web of Science ®Google Scholar
• Ren, S., Luo, X. and Atweh, G. (1993). The major regulatory element upstream of the alpha-globin gene has classical and inducible enhancer activity. Blood, 81, 1058–1066.
   PubMed Web of Science ®Google Scholar
• Sharpe, J. A., Wells, D. J., Whitelaw, E., Vyas, P., Higgs, D. R. and Wood, W. G. (1993). Analysis of the human alpha-globin gene cluster in transgenic mice. Proc. Natl. Acad. Sci., 90, 11262–6.
   PubMed Web of Science ®Google Scholar
• Ren, S., Wong, B., Li, J., Luo, X., Wong, P. and Atweh, G. (1996). Production of genetically stable high-titer retroviral vectors that carry a human gamma-globin gene under the control of the alpha-globin locus control region. Blood, 87, 2518–2524.
   PubMed Web of Science ®Google Scholar
• Emery, D., Morrish, F., Li, Q. and Stamatoyannopoulos, G. (1999). Analysis of gamma-globin expression cassettes in retrovirus vectors. Hum. Gene Ther., 10, 877–888.
   PubMed Web of Science ®Google Scholar
• Sabatino, D. E., Cline, A. P., Gallagher, P. G., Garrett, L. J., Stamatoyannopoulos, G., Forget, B. G. and Bodine, D. M. (1998). Substitution of the human beta-spectrin promoter for the human agamma-globin promoter prevents silencing of a linked human beta globin gene in transgenic mice. Mol. Cell. Biol., 18, 6634–40.
   PubMed Web of Science ®Google Scholar